Our results here show that the contribution of AMH to Model 1 (without AFC) is 35.1%, while the contribution of a combination of AMH and AFC in Model 2 (with AFC) is 35.5%, which suggests that AMH could potentially replace AFC in diagnosing or screening PCOS. Here, AMH is linked to polycystic ovary syndrome.